Acadian Asset Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,186	Closed	-$22K	–	2076
2021 Q2	$22K	Sell	2,186 -3,693	-63%	-$41.1K	﹤0.01%	1934
2021 Q1	$69K	Buy	5,879 +2,315	+65%	+$38.9K	﹤0.01%	1759
2020 Q4	$127K	Sell	3,564 -1,597	-31%	-$27.5K	﹤0.01%	1683
2020 Q3	$71K	Sell	5,161 -30,884	-86%	-$462K	﹤0.01%	1762
2020 Q2	$594K	Buy	+36,045	New	+$429K	﹤0.01%	1140
2020 Q1	–	Sell	-57,069	Closed	-$1.3M	–	1965
2019 Q4	$1.3M	Sell	57,069 -5,084	-8%	-$72.5K	0.01%	813
2019 Q3	$889K	Buy	62,153 +1,454	+2%	+$21.3K	﹤0.01%	922
2019 Q2	$808K	Buy	60,699 +15,801	+35%	+$239K	﹤0.01%	859
2019 Q1	$780K	Buy	44,898 +9,175	+26%	+$137K	﹤0.01%	978
2018 Q4	$489K	Buy	35,723 +3,602	+11%	+$63.4K	﹤0.01%	909
2018 Q3	$691K	Buy	32,121 +3,403	+12%	+$103K	﹤0.01%	812
2018 Q2	$1.23M	Buy	+28,718	New	+$1.32M	0.01%	683
2018 Q1	–	Sell	-2,163	Closed	-$158K	–	1869
2017 Q4	$158K	Buy	2,163 +1,530	+242%	+$127K	﹤0.01%	1001
2017 Q3	$58K	Buy	+633	New	+$48.5K	﹤0.01%	1088
2017 Q1	–	Sell	-2,705	Closed	-$250K	–	1811
2016 Q4	$250K	Buy	+2,705	New	+$305K	﹤0.01%	978
2016 Q2	–	Sell	-73,042	Closed	-$12M	–	1555
2016 Q1	$12M	Sell	73,042 -17,486	-19%	-$3.54M	0.06%	254
2015 Q4	$29.6M	Buy	90,528 +28,313	+46%	+$9.22M	0.15%	163
2015 Q3	$20.1M	Buy	62,215 +18,814	+43%	+$8.27M	0.11%	194
2015 Q2	$17.3M	Buy	+43,401	New	+$18.4M	0.08%	212